PT Ekadharma International Tbk
IDX:EKAD.JK
226 (IDR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 518,358.927 | 614,476.876 | 629,879.335 | 671,540.879 | 758,299.365 | 739,578.86 | 643,591.824 | 568,638.833 | 531,537.607 | 526,573.62 | 418,668.758 | 385,037.05 |
| Cost of Revenue
| 346,092.943 | 431,979.784 | 414,882.738 | 456,477.317 | 546,659.419 | 545,580.195 | 455,607.285 | 374,997.758 | 383,056.995 | 393,247.28 | 302,892.569 | 285,107.987 |
| Gross Profit
| 172,265.984 | 182,497.092 | 214,996.597 | 215,063.562 | 211,639.946 | 193,998.665 | 187,984.538 | 193,641.074 | 148,480.611 | 133,326.34 | 115,776.189 | 99,929.063 |
| Gross Profit Ratio
| 0.332 | 0.297 | 0.341 | 0.32 | 0.279 | 0.262 | 0.292 | 0.341 | 0.279 | 0.253 | 0.277 | 0.26 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 96,883.182 | 100,064.083 | 99,524.248 | 101,374.579 | 110,663.063 | 100,005.032 | 87,410.322 | 0 | 0 | 24,097.252 | 19,878.911 | 17,180.962 |
| Selling & Marketing Expenses
| 555.676 | 411.162 | 428.447 | 478.738 | 1,288.814 | 2,282.543 | 213.059 | 0 | 0 | 43,505.175 | 34,871.628 | 29,971.42 |
| SG&A
| 97,438.858 | 93,410.513 | 81,715.896 | 90,547.36 | 100,999.365 | 95,466.819 | 82,811.213 | 73,145.915 | 71,440.239 | 68,489.194 | 55,513.902 | 47,915.229 |
| Other Expenses
| -2,816.01 | 0 | -1,607.502 | -12.23 | -1,954.927 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 94,622.848 | 93,410.513 | 83,323.398 | 90,559.59 | 102,954.292 | 95,466.819 | 82,811.213 | 73,145.915 | 71,440.239 | 70,079.96 | 60,469.573 | 48,184.989 |
| Operating Income
| 77,643.136 | 89,086.579 | 131,673.199 | 124,503.972 | 108,685.654 | 98,531.846 | 105,173.325 | 120,495.159 | 77,040.373 | 64,837.147 | 60,262.288 | 52,013.835 |
| Operating Income Ratio
| 0.15 | 0.145 | 0.209 | 0.185 | 0.143 | 0.133 | 0.163 | 0.212 | 0.145 | 0.123 | 0.144 | 0.135 |
| Total Other Income Expenses Net
| 9,728.909 | 8,711.197 | 6,024.082 | -1,116.665 | 3,148.848 | 2,923.57 | -2,524.016 | -2,046.129 | -10,733.454 | -5,808.989 | -8,273.985 | -4,083.335 |
| Income Before Tax
| 87,372.045 | 97,797.776 | 137,697.281 | 123,387.307 | 111,834.502 | 101,455.416 | 102,649.31 | 118,449.03 | 66,306.918 | 59,028.158 | 51,988.303 | 47,930.5 |
| Income Before Tax Ratio
| 0.169 | 0.159 | 0.219 | 0.184 | 0.147 | 0.137 | 0.159 | 0.208 | 0.125 | 0.112 | 0.124 | 0.124 |
| Income Tax Expense
| 13,305.383 | 19,831.649 | 29,229.679 | 27,593.584 | 34,431.929 | 27,410.228 | 26,453.644 | 27,763.208 | 19,266.662 | 18,042.294 | 12,537.65 | 11,732.752 |
| Net Income
| 71,944.461 | 76,720.825 | 104,409.665 | 93,502.477 | 73,765.183 | 72,355.266 | 75,355.058 | 87,814.993 | 47,148.747 | 40,272.72 | 38,853.31 | 35,970.305 |
| Net Income Ratio
| 0.139 | 0.125 | 0.166 | 0.139 | 0.097 | 0.098 | 0.117 | 0.154 | 0.089 | 0.076 | 0.093 | 0.093 |
| EPS
| 20.59 | 21.96 | 29.88 | 26.76 | 21.11 | 20.71 | 21.57 | 25.13 | 13.49 | 11.53 | 11.12 | 10.3 |
| EPS Diluted
| 20.59 | 21.96 | 29.88 | 26.76 | 21.11 | 20.71 | 21.57 | 25.13 | 13.49 | 11.53 | 11.12 | 10.3 |
| EBITDA
| 83,980.441 | 109,418.665 | 154,940.394 | 148,893.817 | 131,564.87 | 121,335.037 | 125,117.636 | 135,136.88 | 86,678.787 | 75,786.513 | 69,226.686 | 59,571.303 |
| EBITDA Ratio
| 0.162 | 0.178 | 0.246 | 0.222 | 0.173 | 0.164 | 0.194 | 0.238 | 0.163 | 0.144 | 0.165 | 0.155 |